Skip to content

Abstract C155: Immune profiling reveals distinct ancestry-associated immune surveillance programmes in breast cancer

Oct 2026 · Cancer Epidemiology, Biomarkers & Prevention · 0 citations

TL;DR

A large multimodal study integrating clinical, systemic and spatial immune profiling to investigate ethnicity-associated immune surveillance while minimizing socioeconomic confounding demonstrates divergent ancestry-associated alterations in immune surveillance profiles, which likely contributes to mechanisms underpinning inequitable breast cancer outcomes.

Abstract

Black women with breast cancer experience poorer outcomes than White women. It is recognized that an array of factors including ancestry and socioeconomic status, including environmental inequalities, as well as surveillance landscape affect this disparity. However, the specific contribution of genetic ancestry to anti-tumor immunity remains poorly understood. As ancestry, socioeconomic and environmental disadvantage are intertwined, distinguishing immune programmes associated with each factor has been challenging. Focusing on treatment naïve early breast cancer patients, we therefore performed a large multimodal study integrating clinical, systemic and spatial immune profiling to investigate ethnicity-associated immune surveillance while minimizing socioeconomic confounding. Clinical characteristics, whole blood counts, Index of Multiple Deprivation (IMD) were available for 810 breast cancer patients (598 White; 212 Black) and 87 healthy controls. A subset of patients have estimates of genetic ancestry available, complementing self-reported ethnicity. High-dimensional flow cytometry was performed in 155 patients (104 White; 51 Black), high-throughput Olink serum proteomics in 104 patients (63 White; 41 Black), digital pathology in 219 tumor-draining lymph nodes from 88 patients, CD20/CD3 IHC was performed in 211 lymph nodes from 92 patients and 20-plex PhenoCycler imaging in 30 lymph nodes (17 White; 13 Black). To identify immune programmes specifically associated with ancestry, analyses were performed by adjusting for age, stage, subtype and IMD. Independent of these confounders, black patients exhibited reduced neutrophil-to-lymphocyte ratio, inhibitory NK-cell phenotypes, expansion of cDC1s and activated antigen-presenting monocytes, together with a pro-inflammatory chemokine signature. Spatial imaging revealed remodeling of tumor-draining lymph node immune architecture, with reduced GZMB+ CD8+ T cells, altered B-cell zone organization and increased M2-like macrophages in B cell zone of involved lymph nodes. Comprehensive H&E and CD20/CD3 IHC analyses of the full lymph node cohort are ongoing and will provide additional validation of spatial immune alterations identified by high-dimensional imaging. This multimodal study demonstrates differential circulating and lymphoid immune signatures associated specifically with ancestry. While several systemic and lymph node immune programmes persisted after minimizing socioeconomic confounding, others were more associated with deprivation indices and environmental inequalities, indicating complementary influences on immune organization. These findings demonstrate divergent ancestry-associated alterations in immune surveillance profiles, which likely contributes to mechanisms underpinning inequitable breast cancer outcomes. Bryan Boon Han Ng, Paul R. Buckley, Thanussuyah Alaguthurai, Helen Kakkassery, Tara Chait, Katie Broome, Benjamin Nicholls-Mindlin, Sophie Stewart, Rosalind Graham, Ruifang Lu, Esme Carpenter, Melek Akay, Hiu-Yan Lau, Yi-Ting Tsai, Farhana Hossain, Syed Haider, Nigel Mongan, Fieke Froeling, Clayton Yates, Melissa Davis, Patrycja Gazinska, Sheeba Irshad. Immune profiling reveals distinct ancestry-associated immune surveillance programmes in breast cancer [abstract]. In: Proceedings of the 19th AACR Conference on the Science of Cancer Health Disparities; 2026 Oct 18-21; Atlanta, GA. Philadelphia (PA): AACR; Cancer Epidemiol Biomarkers Prev 2026;35(10 Suppl):Abstract nr C155.

View source

Similar papers

Oct 2026

Abstract C130: A genetic ancestry-informed single-cell atlas of the endometrial cancer tumor microenvironment reveals ancestry-associated immune features with potential clinical implications

Genetic ancestry-associated differences in the tumor immune profile have been identified in multiple cancer types but remain largely uncharacterized in endometrial cancer (EC). These tumor microenvironment (TME) features, such as cytotoxic immune cell infiltration and functionality, influence disease progression, tum...

Emma Saart, K. Lundy-Perez, N. Chambwe · 0 citations
Oct 2026

Abstract C126: Integrated whole genome and transcriptome analyses reveal ancestry-associated molecular features of breast cancer

An African ancestry-enriched whole genome and transcriptome sequencing cohort is leveraged to investigate the relative influence of genetic ancestry and clinical factors on breast cancer gene expression and establish a framework for identifying ancestry-associated regulatory mechanisms underlying BC disparities.

Rachel Martini, William Hooper, Timothy R. Chu et al. · 0 citations
Oct 2026

Abstract B049: Landscape of genetic ancestry-associated active drugs unique to or shared by White and Hispanic children with group 3 medulloblastomas

This study uncovers reproducible genetic ancestry-based drug response profile between white and Hispanic G3 MBs, provides a biologic rational for mechanistic investigation of cancer disparities and supports the development of ancestry-informed precision therapeutic strategies for medulloblastoma.

Jin-Nan Chen, Yi-Ming Mei, Xin Zhai et al. · 0 citations
#gene editing Review Oct 2026

Abstract A187: A transitional molecular state predicts early mortality and is differentially represented across racial groups in ER-positive breast cancer

Black women with ER-positive breast cancer experience higher mortality than White women despite comparable diagnoses, yet standard receptor-based classification treats ER+ tumors as biologically uniform. We hypothesized that a coordinated transitional molecular state, rather than any single gene, is differentially re...

Audrey Guo · 0 citations
Oct 2026

Abstract C147: U54 Cancer Health Disparities Specialized Program of Research Excellence: The Lymphoma Outcomes SPORE

Diffuse large B-cell lymphoma (DLBCL), the most common hematologic cancer in the US, is characterized by marked molecular and clinical heterogeneity. African American (AA) and Hispanic patients experience inferior outcomes due to biologic factors that remain poorly understood, in addition to well-described socioecono...

J. Koff, Jonathon B. Cohen, Lee A. D. Cooper et al. · 0 citations
Oct 2026

Abstract B100: Germline genetics of chronic inflammation and breast cancer risk in Peru: Building population-specific resources for precision prevention in Latin America

Breast cancer is the leading cause of cancer-related mortality among women, particularly in Low and Middle-Income Countries (LMICs), including Peru. Reportedly, the Peruvian population possess substantial Indigenous American ancestry, which remains underrepresented in genomic studies. Chronic inflammation contributes...

Solange R. Paredes-Moscosso, Xiao-Song Huang, Amanda F. Corpuz et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.